文献速递糖尿病

与糖尿病共度健康老龄:技术的作用

Ageing well with diabetes: the role of technology.
PubMed 文献 · Diabetologia · 2024-08-13

过去二十年,糖尿病治疗技术在儿童、青少年和年轻成人1型糖尿病中的应用大幅增加,现在也被倡导用于老年人。老年人因多种易感因素更易发生低血糖,且低血糖可能导致认知障碍、衰弱和残疾。持续葡萄糖监测系统、胰岛素泵、自动胰岛素输注系统和智能胰岛素笔等技术在临床试验和真实世界研究中显示可改善血糖管理、减少低血糖事件、急诊就诊和住院,并提高生活质量,但衰老带来的身体损伤可能阻碍技术使用。医疗专业人员应识别可能受益的老年人并采取个体化教育和随访。

要点

  • 老年人糖尿病常伴有显著血糖波动,与年龄相关变化如食欲和体力活动水平变化、合并症和多药治疗有关。
  • 技术包括持续葡萄糖监测系统、胰岛素泵、自动胰岛素输注系统和智能胰岛素笔。
  • 临床试验和真实世界研究表明老年糖尿病患者从技术中获益,包括血糖管理、减少低血糖事件、急诊就诊和住院以及改善生活质量。

核心结论

  • 老年人糖尿病常以显著血糖波动为特征,与年龄相关变化如食欲和体力活动水平变化、合并症和多药治疗有关。
  • 预防低血糖和减轻血糖波动可能对身体和认知功能及总体健康有显著积极影响,甚至可能预防或改善衰弱。
  • 医疗专业人员应识别可能受益于治疗技术的老年糖尿病患者,并对个人及其照护者采取个体化教育和随访方法。
  • 未来研究应探索糖尿病技术对老年糖尿病患者相关结局的影响。

研究设计与样本

  • 原文为综述,未报告系统检索范围。

主要发现

  • 临床试验和真实世界研究表明老年糖尿病患者从技术中获益,包括血糖管理、减少低血糖事件、急诊就诊和住院以及改善生活质量。
  • 衰老可能带来身体损伤和其他挑战,阻碍技术的使用。

临床怎么用

  • 医疗专业人员应识别可能受益于治疗技术的老年糖尿病患者,并对个人及其照护者采取个体化教育和随访方法。

局限性

  • 衰老可能带来身体损伤和其他挑战,阻碍技术的使用。
  • 未来研究应探索糖尿病技术对老年糖尿病患者相关结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the past two decades there has been a substantial rise in the adoption of diabetes therapeutic technology among children, adolescents and younger adults with type 1 diabetes, and its use is now also advocated for older individuals. Older people with diabetes are more prone to experience hypoglycaemia because of numerous predisposing factors and are at higher risk of hypoglycaemic events requiring third-party assistance as well as other adverse sequelae. Hypoglycaemia may also have long-term consequences, including cognitive impairment, frailty and disability. Diabetes in older people is often characterised by marked glucose variability related to age-associated changes such as variable appetite and levels of physical activity, comorbidities and polypharmacotherapy. Preventing hypoglycaemia and mitigating glucose excursions may have considerable positive impacts on physical and cognitive function and general well-being and may even prevent or improve frailty. Technology for older people includes continuous glucose monitoring systems, insulin pumps, automated insulin delivery systems and smart insulin pens. Clinical trials and real-world studies have shown that older people with diabetes benefit from technology in terms of glucose management, reductions in hypoglycaemic events, emergency department attendance and hospital admissions, and improvement in quality of life. However, ageing may bring physical impairments and other challenges that hinder the use of technology. Healthcare professionals should identify older adults with diabetes who may benefit from therapeutic technology and then adopt an individualised approach to education and follow-up for individuals and their caregivers. Future research should explore the impact of diabetes technology on outcomes relevant to older people with diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Maltese G, McAuley SA, Trawley S, et al. Ageing well with diabetes: the role of technology. Diabetologia. 2024. PMID: 39138689. doi:10.1007/s00125-024-06240-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。